GB0802576D0 - Dosage form - Google Patents

Dosage form

Info

Publication number
GB0802576D0
GB0802576D0 GB0802576A GB0802576A GB0802576D0 GB 0802576 D0 GB0802576 D0 GB 0802576D0 GB 0802576 A GB0802576 A GB 0802576A GB 0802576 A GB0802576 A GB 0802576A GB 0802576 D0 GB0802576 D0 GB 0802576D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0802576A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GB0802576A priority Critical patent/GB0802576D0/en
Publication of GB0802576D0 publication Critical patent/GB0802576D0/en
Ceased legal-status Critical Current

Links

GB0802576A 2008-02-12 2008-02-12 Dosage form Ceased GB0802576D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0802576A GB0802576D0 (en) 2008-02-12 2008-02-12 Dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0802576A GB0802576D0 (en) 2008-02-12 2008-02-12 Dosage form

Publications (1)

Publication Number Publication Date
GB0802576D0 true GB0802576D0 (en) 2008-03-19

Family

ID=39247516

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0802576A Ceased GB0802576D0 (en) 2008-02-12 2008-02-12 Dosage form

Country Status (1)

Country Link
GB (1) GB0802576D0 (en)

Similar Documents

Publication Publication Date Title
GB0909680D0 (en) Dosage form
IL237392A0 (en) Pharmaceutical combination
ZA201400310B (en) Solid dosage form
IL207128A0 (en) Pharmaceutical dosage form
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
GB0816371D0 (en) Pharmaceutical compounds
ZA200903858B (en) Pharmaceutical dosage form
GB0812969D0 (en) Pharmaceutical compounds
HK1137363A1 (en) Novel dosage form
PL2271618T3 (en) Pharmaceutical compounds
GB0816370D0 (en) Pharmaceutical compounds
HK1152640A1 (en) Pharmaceutical combination
GB0810857D0 (en) Pharmaceutical compounds
GB0803054D0 (en) Medicament
GB0822124D0 (en) Oral dosage form
HUP0800414A2 (en) Pharmaceutical combination
GB0802576D0 (en) Dosage form
GB0704123D0 (en) Dosage form
GB0803395D0 (en) Medicament
GB0807502D0 (en) Pharmaceutical compounds
GB0805300D0 (en) Pharmaceutical compounds
GB0802252D0 (en) Pharmaceutical compounds
GB0817006D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)